Turnstone Biologics Inc.

turnstonebio.com
Innovation Type:
Therapeutics
Cancer Type:
Multiple
Funding Stage:
Series A,B,C
Fund:
Compass Rose
Transforming patient care with a new class of targeted viral immunotherapies to fight cancer (Marabavirus-based oncolytic viral vector)

Related news

    CONNECT WITH FACIT

    Learn more about how we are driving made-in-Ontario oncology innovations reach the market.